Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-23-113277
Filing Date
2023-11-01
Accepted
2023-11-01 12:24:40
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm2329368d3_424b5.htm 424B5 352853
2 GRAPHIC tm2310905d1_424b5img01.jpg GRAPHIC 3804
3 GRAPHIC tm2329368d1_42b5img001.jpg GRAPHIC 3634
4 GRAPHIC tm2329368d1_42b5supimg002.jpg GRAPHIC 3638
  Complete submission text file 0001104659-23-113277.txt   369655
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-252625 | Film No.: 231367318
SIC: 2834 Pharmaceutical Preparations